- Report
- November 2023
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- November 2023
- 171 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- June 2023
- 111 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- August 2023
- 166 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- February 2024
- 118 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2024
- 140 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- November 2023
- 86 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- November 2023
- 110 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- March 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- February 2024
- 380 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- January 2024
- 62 Pages
Europe
From €2847EUR$2,950USD£2,442GBP
- Report
- June 2023
- 105 Pages
United States
From €5743EUR$5,950USD£4,926GBP
- Report
- May 2018
- 124 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- May 2022
- 190 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Report
- December 2021
- 206 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2896EUR$3,000USD£2,484GBP
The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more